Moreover, urinary levels of NE and elafin—an NE inhibitor—have significant diagnostic value in differentiating IBD patients from healthy controls [184] and NGAL levels are high and sensitive in determining diagnosis and disease activity in IBD patients [185]. This evidence concerns the gene LCN2 and irritable bowel syndrome.